Caprion Pharmaceuticals, J&J deal

JNJ’s Ortho-Clinical Diagnostics unit (Raritan, N.J.) and Caprion will develop a human blood test for variant Creutzfeldt-Jacob Disease (vCJD), extending the companies’ April research deal under which...